Galapagos NV’s service division, BioFocus DPI, will provide compound management and related services to Sepracor for a total contract value of $1.5 million. Under the terms of the agreement, BioFocus DPI will receive, register, and store selected compounds from Sepracor’s compound library, and plate and replicate these compounds for three years. Services will be provided by BioFocus DPI’s compound management facility in San Francisco, CA.
   
“We welcome Sepracor as a new client to BioFocus DPI,” said Onno van de Stolpe, chief executive officer of Galapagos. “Our compound management site has been able to broaden its customer base over the last year, and with this agreement we further expand our list of pharma companies.”